ONXEO
Dead / Cancelled — Cancelled — Section 8 (as of 03 Apr 2026)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86288671
- Registration number
- 4815827
- Mark type
- Design + words
- Filed
- 22 May 2014
- Published for opposition
- 10 Mar 2015
- Registered
- 22 Sept 2015
- Attorney of record
- Ben Natter
Goods and services
- Class 042 — Scientific and technological services: product research, namely, research services for conceiving and developing innovative products in the field of oncology
Owner
- VALERIO THERAPEUTICS S.A., PARIS, FR
- ONXEO, Paris, FR
- BIOALLIANCE PHARMA, Paris, FR
- BIOALLIANCE PHARMA, Paris, FR
- BIOALLIANCE PHARMA, Paris, FR
Prosecution history
- 03 Apr 2026 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 22 Sept 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 26 Jul 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 24 Jul 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 24 Jul 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Jul 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Jul 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Jul 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 24 Jul 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 30 Jun 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 30 Jun 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 27 Jun 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Feb 2021 — TEAS SECTION 8 & 15 RECEIVED
- 22 Sept 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Sept 2015 — REGISTERED-PRINCIPAL REGISTER